SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

26 hedge funds and large institutions have $421M invested in Sinovac Biotech, Ltd in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$76.3M
2
+$1.04M
3
+$849K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$179K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$106K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$340M
2
$76.3M
3
$2.04M
4
$1.04M
5
$849K
6
$179K
7
$106K
8
$82.5K
9
$44.8K
10
$19.4K
11
$13.6K
12
$2.67K
13
$1K
14
$336